B of A Securities Maintains Underperform on Ardent Health, Raises Price Target to $14
Benzinga Newsdesk 10 hours ago
Analyst RatingsNewsPrice Target
B of A Securities analyst Kevin Fischbeck maintains Ardent Health (NYSE:ARDT) with a Underperform and raises the price target from $12 to $14.
B of A Securities analyst Kevin Fischbeck maintains Ardent Health (NYSE:ARDT) with a Underperform and raises the price target from $12 to $14.